72 related articles for article (PubMed ID: 9811172)
1. Immunotherapeutic potential of JL1, a thymocyte surface protein, for leukemia.
Kim TJ; Park SH
J Korean Med Sci; 1998 Oct; 13(5):455-8. PubMed ID: 9811172
[TBL] [Abstract][Full Text] [Related]
2. A cell surface molecule, JL1; a specific target for diagnosis and treatment of leukemias.
Park WS; Bae YM; Chung DH; Kim TJ; Choi EY; Chung JK; Lee MC; Park SY; Park MH; Park SH
Leukemia; 1998 Oct; 12(10):1583-90. PubMed ID: 9766503
[TBL] [Abstract][Full Text] [Related]
3. JL1, a novel differentiation antigen of human cortical thymocyte.
Park SH; Bae YM; Kwon HJ; Kim TJ; Kim J; Lee SJ; Lee SK
J Exp Med; 1993 Oct; 178(4):1447-51. PubMed ID: 8376947
[TBL] [Abstract][Full Text] [Related]
4. Targeted cytotoxic effect of anti-JL1 immunotoxin against a human leukemic cell line and its clinical implications.
Shin YK; Choi YL; Choi EY; Kim MK; Kook MC; Chung J; Choi YK; Kim HS; Song HG; Park SH
Cancer Immunol Immunother; 2003 Aug; 52(8):506-12. PubMed ID: 12768327
[TBL] [Abstract][Full Text] [Related]
5. Expression of leukemia-associated antigen, JL1, in bone marrow and thymus.
Shin YK; Choi EY; Kim SH; Chung J; Chung DH; Park WS; Jung KC; Kim HS; Park S; Kim HJ; Park MH; Min CK; Kim CC; Park SH
Am J Pathol; 2001 Apr; 158(4):1473-80. PubMed ID: 11290565
[TBL] [Abstract][Full Text] [Related]
6. Expression of JL1 is an effective adjunctive marker of leukemia cutis.
Park YS; Park SH; Park SJ; Kim Y; Jang KT; Ko YH; Lee MW; Huh JR; Park CS
Arch Pathol Lab Med; 2010 Jan; 134(1):95-102. PubMed ID: 20073611
[TBL] [Abstract][Full Text] [Related]
7. Identification of antigenic peptide recognized by the anti-JL1 leukemia-specific monoclonal antibody from combinatorial peptide phage display libraries.
Chung J; Park S; Kim D; Rhim J; Kim I; Choi I; Yi K; Ryu S; Suh P; Chung D; Bae Y; Shin Y; Park S
J Cancer Res Clin Oncol; 2002 Dec; 128(12):641-9. PubMed ID: 12474050
[TBL] [Abstract][Full Text] [Related]
8. The Incidence and Immunophenotypic and Genetic Features of JL1 Expressing Cells and the Therapeutic Potential of an Anti-JL1 Antibody in
Park SH; You E; Park CJ; Jang S; Cho YU; Yoon CH; Koh KN; Im HJ; Seo JJ
Ann Lab Med; 2019 Jul; 39(4):358-366. PubMed ID: 30809981
[TBL] [Abstract][Full Text] [Related]
9. A novel cell surface antigen, immature thymocyte antigen-1, is involved in the differentiation of murine thymocytes.
Kishi H; Su DM; Muraguchi A; Watanabe T
J Immunol; 1995 Jul; 155(2):568-77. PubMed ID: 7608536
[TBL] [Abstract][Full Text] [Related]
10. Identification of several cell surface proteins of non-T, non-B acute lymphoblastic leukemia by using monoclonal antibodies.
Quackenbush EJ; Letarte M
J Immunol; 1985 Feb; 134(2):1276-85. PubMed ID: 3155538
[TBL] [Abstract][Full Text] [Related]
11. [ICO-10 monoclonal antibodies to the Thy-1 antigen].
Korotkova OV; Baryshnikov AIu; Tupitsyn NN; Chimishkian KL; Kostrykina VN
Eksp Onkol; 1989; 11(2):33-5. PubMed ID: 2567662
[TBL] [Abstract][Full Text] [Related]
12. The reliability of cytoplasmic CD3 and CD22 antigen expression in the immunodiagnosis of acute leukemia: a study of 500 cases.
Janossy G; Coustan-Smith E; Campana D
Leukemia; 1989 Mar; 3(3):170-81. PubMed ID: 2465463
[TBL] [Abstract][Full Text] [Related]
13. A novel human leukocyte differentiation antigen: monoclonal antibody anti-D44 defines a 28 Kd molecule present on immature hematologic cells and a subpopulation of mature T cells.
Bernard A; Gay-Bellile V; Amiot M; Caillou B; Charbord P; Boumsell L
J Immunol; 1984 May; 132(5):2338-44. PubMed ID: 6425401
[TBL] [Abstract][Full Text] [Related]
14. JL1 Antigen Expression on Bone Marrow Lymphoma Cells from Patients With Non-Hodgkin Lymphoma.
Kim MS; Park CJ; Cho YU; Jang S; Seo EJ; Park CS; Huh J; Im HJ; Seo JJ; Yoon DH; Suh C
Ann Lab Med; 2020 Jan; 40(1):1-6. PubMed ID: 31432632
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo properties of murine monoclonal antibody for a novel immature thymocyte-differentiated antigen, JL1.
Chung JK; So Y; Hong MK; Choi SR; Jeong JM; Lee DS; Lee MC; Koh CS; Choi EY; Park SH
Nucl Med Biol; 1997 Jul; 24(5):433-7. PubMed ID: 9290079
[TBL] [Abstract][Full Text] [Related]
16. The cytoplasmic expression of CD3 antigens in normal and malignant cells of the T lymphoid lineage.
Campana D; Thompson JS; Amlot P; Brown S; Janossy G
J Immunol; 1987 Jan; 138(2):648-55. PubMed ID: 3098852
[TBL] [Abstract][Full Text] [Related]
17. Flow cytometric analysis of cell-surface and intracellular antigens in leukemia diagnosis.
Knapp W; Strobl H; Majdic O
Cytometry; 1994 Dec; 18(4):187-98. PubMed ID: 7534675
[TBL] [Abstract][Full Text] [Related]
18. Leukemia-specific siRNA delivery by immunonanoplexes consisting of anti-JL1 minibody conjugated to oligo-9 Arg-peptides.
Lee YK; Kim KS; Kim JS; Baek JE; Park SI; Jeong HY; Yoon SS; Jung KC; Song HG; Park YS
Mol Cells; 2010 May; 29(5):457-62. PubMed ID: 20396968
[TBL] [Abstract][Full Text] [Related]
19. A lymphocyte differentiation and activation antigen, CZ-1, that distinguishes between CD8+ and unstimulated CD4+ T lymphocytes.
Vargas-Cortes M; O'Donnell CL; Appel MC; Maciaszek JW; Yurkunas KS; Welsh RM
Eur J Immunol; 1992 Apr; 22(4):1043-7. PubMed ID: 1348027
[TBL] [Abstract][Full Text] [Related]
20. The analogy in cell immunophenotype and parameters of cell cycle of ectopic thymus, normal thymus, and some acute lymphoblastic leukemia of T-phenotype.
Babusíková O; Tomová A
Neoplasma; 2002; 49(5):312-8. PubMed ID: 12458329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
